Trimethadione (Tridione)-induced nephrotic syndrome. A report of a case with unique ultrastructural renal pathology.
D000293:Adolescent; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001485:Basement Membrane; D002448:Cell Adhesion; D004342:Drug Hypersensitivity / Q000175:diagnosis; D004727:Endothelium / Q000473:pathology; D004804:Eosinophils; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007668:Kidney / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D010080:Oxazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D010080:Oxazoles